Aerosol formulation
AssigneeBoehringer Ingelheim International GmbH
InventorsChristel Schmelzer, Rainer Weitzel
Life of this patent
Estimating the term…
Abstract
The present invention relates to propellant-free aerosol formulations for inhalation containing ipratropium bromide and salbutamol.
Claims10
A propellant-free solution formulation for inhalation which contain the active substances salbutamol, optionally in the form of the pharmacologically acceptable acid addition salts thereof, and ipratropium bromide and optionally further excipients, in a solvent selected from among water, ethanol and water-ethanol mixtures, the weight ratio of salbutamol to ipratropium bromide being in the range from 2:1 to 3:1 and the solution formulation containing no other active substances.
Dependencies are inferred from the claim text.